228 related articles for article (PubMed ID: 33982815)
41. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
Park S; Ko YH
J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
[TBL] [Abstract][Full Text] [Related]
42. Clinicopathological characteristics of four cases of EBV positive T-cell lymphoproliferative disorders of childhood in China.
Huang W; Lv N; Ying J; Qiu T; Feng X
Int J Clin Exp Pathol; 2014; 7(8):4991-9. PubMed ID: 25197370
[TBL] [Abstract][Full Text] [Related]
43. Hydroa vacciniforme-like lymphoproliferative disorder: a retrospective cohort study of seven pediatric cases.
Ren F; Zhu J; Perry DM; Pruitt L; Elston DM
Int J Dermatol; 2020 Aug; 59(8):e290-e292. PubMed ID: 32403170
[No Abstract] [Full Text] [Related]
44. Hydroa Vacciniforme-Like EBV-Positive Cutaneous T-Cell Lymphoma, First Report of 2 Cases in Ecuador.
Montalvo N; Redrobán L
Am J Dermatopathol; 2016 May; 38(5):e57-9. PubMed ID: 26913846
[TBL] [Abstract][Full Text] [Related]
45. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
[TBL] [Abstract][Full Text] [Related]
46. Clonal expansion of Epstein-Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions.
Wada T; Toga A; Sakakibara Y; Toma T; Hasegawa M; Takehara K; Shigemura T; Agematsu K; Yachie A
Int J Hematol; 2012 Oct; 96(4):443-9. PubMed ID: 22886572
[TBL] [Abstract][Full Text] [Related]
47. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
[TBL] [Abstract][Full Text] [Related]
48. The association of latent Epstein-Barr virus infection with hydroa vacciniforme.
Iwatsuki K; Xu Z; Takata M; Iguchi M; Ohtsuka M; Akiba H; Mitsuhashi Y; Takenoshita H; Sugiuchi R; Tagami H; Kaneko F
Br J Dermatol; 1999 Apr; 140(4):715-21. PubMed ID: 10233328
[TBL] [Abstract][Full Text] [Related]
49. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
50. An update on viral-induced cutaneous lymphoproliferative disorders. CME Part I.
Plaza JA; Gru AA; Sangueza OP; Lourenco SV; Puccio FB; Sanches JA; Miyashiro D; Toussaint S; Sangueza MJ
J Am Acad Dermatol; 2023 May; 88(5):965-980. PubMed ID: 36041557
[TBL] [Abstract][Full Text] [Related]
51. The aim of the measurement of Epstein-Barr virus DNA in hydroa vacciniforme and hypersensitivity to mosquito bites.
Miyake T; Iwatsuki K; Hirai Y; Yamamoto T; Hamada T; Fujii K; Imamura H; Morizane S
J Med Virol; 2020 Dec; 92(12):3689-3696. PubMed ID: 32255500
[TBL] [Abstract][Full Text] [Related]
52. Hydroa vacciniforme and solar urticaria.
Nitiyarom R; Wongpraparut C
Dermatol Clin; 2014 Jul; 32(3):345-53, viii. PubMed ID: 24891056
[TBL] [Abstract][Full Text] [Related]
53. Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases.
Sangueza M; Plaza JA
J Am Acad Dermatol; 2013 Jul; 69(1):112-9. PubMed ID: 23541598
[TBL] [Abstract][Full Text] [Related]
54. Artificial reproduction of atypical hydRoa vacciniforme caused by latent EpStein-Barr virus infection.
Heo EP; Park SH; Kim TH
Int J Dermatol; 2003 Jun; 42(6):476-9. PubMed ID: 12854510
[TBL] [Abstract][Full Text] [Related]
55. Hydroa vacciniforme-like lymphoproliferative disorder with eye involvement.
Feng X; Li F; Zhang Y; Wang L
Pediatr Dermatol; 2021 Sep; 38(5):1387-1388. PubMed ID: 34561883
[TBL] [Abstract][Full Text] [Related]
56. Hydroa vacciniforme-like eruptions in a patient with chronic active EB virus infection.
Katagiri Y; Mitsuhashi Y; Kondo S; Kanazawa C; Iwatsuki K; Tsunoda T
J Dermatol; 2003 May; 30(5):400-4. PubMed ID: 12773806
[TBL] [Abstract][Full Text] [Related]
57. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.
Kimura H; Ito Y; Kawabe S; Gotoh K; Takahashi Y; Kojima S; Naoe T; Esaki S; Kikuta A; Sawada A; Kawa K; Ohshima K; Nakamura S
Blood; 2012 Jan; 119(3):673-86. PubMed ID: 22096243
[TBL] [Abstract][Full Text] [Related]
58. Differentiating Between Epstein-Barr Virus-positive Lymphoid Neoplasm Relapse and Post-transplant Lymphoproliferative Disorder After Sex-mismatched Hematopoietic Stem Cell Transplantation.
Kurashige R; Kurashige M; Okada Y; Higuchi K; Yuda S; Hino A; Miyamura T; Ichii M; Fukushima K; Honma K; Takeuchi M; Yokota T; Ishikawa J; Sawada A; Shibayama H; Hosen N; Morii E
Am J Surg Pathol; 2024 Apr; 48(4):395-405. PubMed ID: 38287877
[TBL] [Abstract][Full Text] [Related]
59. Hydroa Vacciniforme-like Lymphoproliferative Disorder Treated with Intravenous Immunoglobulin: Long-term Remission Without Haematopoietic Stem Cell Transplantation or Chemotherapy.
Ruan Y; Shen X; Shi R; Zhao X; Zheng J
Acta Derm Venereol; 2020 Jun; 100(13):adv00192. PubMed ID: 32516422
[No Abstract] [Full Text] [Related]
60. Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites.
Yamamoto T; Hirai Y; Miyake T; Hamada T; Yamasaki O; Morizane S; Fujimoto W; Iwatsuki K
J Dermatol Sci; 2016 Jun; 82(3):153-9. PubMed ID: 27039668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]